Do the benefits of statins outweigh their drawbacks? Assessing patients' trade-off preferences with conjoint analysis

MLA

Wouters, Hans, et al. “Do the Benefits of Statins Outweigh Their Drawbacks? Assessing Patients’ Trade-off Preferences with Conjoint Analysis.” International Journal of Cardiology, vol. 176, Oct. 2014, pp. 1220–22. EBSCOhost, https://doi.org/10.1016/j.ijcard.2014.07.219.

APA

Wouters, H., Van Dijk, L., Van Geffen, E. C. G., Geers, H. C. J., Souverein, P. C., Bouvy, M. L., Stiggelbout, A. M., Sub Pharmacoepidemiology, UIPS - Utrecht Institute for Pharmaceutical Sciences, Sub Gen. Pharmacoepi and Clinical Pharm, & Pharmacoepidemiology and Clinical Pharmacology. (2014). Do the benefits of statins outweigh their drawbacks? Assessing patients’ trade-off preferences with conjoint analysis. International Journal of Cardiology, 176, 1220–1222. https://doi.org/10.1016/j.ijcard.2014.07.219

Chicago

Wouters, Hans, Liset Van Dijk, Erica C G Van Geffen, Harm C J Geers, Patrick C. Souverein, Marcel L. Bouvy, Anne M. Stiggelbout, et al. 2014. “Do the Benefits of Statins Outweigh Their Drawbacks? Assessing Patients’ Trade-off Preferences with Conjoint Analysis.” International Journal of Cardiology 176 (October): 1220–22. doi:10.1016/j.ijcard.2014.07.219.